Emerging evidence has accumulated that NLRP3 inflammasome is activated by these toxic lipids as a pathogenic mechanism for the development of NASH in murine models (21, 73–76). This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.